Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

A woman regrew her hair significantly using a corticosteroid cream with a plastic cover.

A 21-year-old with lichen planopilaris was successfully treated, stopping disease progression and preventing crusts.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Azathioprine can cause hair loss and matted hair.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

The study concluded that hair loss treatments should be tailored to the specific type of alopecia and individual patient needs.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

A young child with alopecia areata and psoriasis improved with treatment, suggesting a link between the two conditions.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

New methods for treating hair loss are being developed.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Targeting the AhR pathway may help treat alopecia areata.

Early diagnosis and treatment can help manage hair loss effectively.

Tufted folliculitis is common in patients with folliculitis decalvans.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

New treatments for alopecia focus on personalized plans to improve hair regrowth and reduce side effects.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Alopecia areata in children is often linked to genetics, autoimmune issues, and stress, and is treated with corticoids or PUVA therapy.

Alopecia areata deeply affects self-esteem and identity, needing both medical and emotional support.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Accurate diagnosis of alopecia areata incognito requires trichoscopy and histopathology.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.